MERTK inhibition selectively activates a DC - T-cell axis to provide anti-leukemia immunity.
Huelse JM, Bhasin SS, Jacobsen KM, Yim J, Thomas BE, Branella GM, Bakhtiari M, Chimenti ML, Baxter TA, Raikar SS, Wang X, Frye SV, Henry CJ, Earp HS, Bhasin M, DeRyckere D, Graham DK.
Huelse JM, et al. Among authors: henry cj.
Leukemia. 2024 Dec;38(12):2685-2698. doi: 10.1038/s41375-024-02408-2. Epub 2024 Sep 25.
Leukemia. 2024.
PMID: 39322710